Triptolide, a compound extracted from the traditional chinese medicine preparation of Tripterygium wilfordii Hook F., can inhibit ovarian cancer invasion and tumor growth in vivo through transcriptional suppression of MMP-7 and MMP-19 [117]. Here, MMP19 is linked to ovarian carcinoma.